clopidogrel has been researched along with mk-0524 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallob, A; De Hoon, JN; De Lepeleire, I; Dishy, V; Johnson-Levonas, AO; Kraft, WK; Lai, E; Luk, JM; Luo, WL; Radziszewski, W; Ratcliffe, L; Schwartz, JI; Van Hecken, A; Wagner, JA | 1 |
| De Kam, PJ; Lai, E; Luo, WL; Radziszewski, W; Ratcliffe, L; Royalty, J; Sisk, CM; Wagner, JA; Wenning, L | 1 |
2 trial(s) available for clopidogrel and mk-0524
| Article | Year |
|---|---|
The effects of laropiprant, a selective prostaglandin Dâ‚‚ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
Topics: Adolescent; Adult; Aspirin; Bleeding Time; Blood Platelets; Clopidogrel; Female; Humans; Indoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Immunologic; Receptors, Prostaglandin; Ticlopidine; Young Adult | 2011 |
The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin.
Topics: Adult; Aged; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Drug Interactions; Dyslipidemias; Female; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Young Adult | 2014 |